David A. Siegel Penumbra Inc Transaction History

Two Sigma Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$116.09 - $227.33 $912,351 - $1.79 Million	7,859 New	7,859 $979,000
Q4 2018 Feb 14, 2019	SELL	$113.42 - $156.48 $12.6 Million - $17.3 Million	-110,859 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$121.55 - $156.8 $12.1 Million - $15.6 Million	99,500 Added 875.96%	110,859 $16.6 Million
Q2 2018 Aug 14, 2018	BUY	$112.2 - $165.95 $567,619 - $839,541	5,059 Added 80.3%	11,359 $1.57 Million
Q1 2018 May 15, 2018	BUY	$84.6 - $126.1 $532,980 - $794,430	6,300 New	6,300 $729,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.09B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.